Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

287.63
Delayed Data
As of Feb 22
 +0.73 / +0.25%
Today’s Change
205.42
Today|||52-Week Range
307.33
+10.12%
Year-to-Date

Today’s Trading

Previous close286.90
Today’s open287.75
Day’s range285.22 - 289.43
Volume1,045,957
Average volume (3 months)1,777,652
Market cap$62.0B
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.78%
Earnings growth (next 5 years)+8.72%
Revenue growth (last year)+9.37%
P/E ratio17.0
Price/Sales6.09
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.46-0.66%
ILMNIllumina Inc+0.15+0.09%
BIVVBioverativ Inc-0.44-0.91%
TECHBio-Techne Corp+0.30+0.28%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$4.99
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs